ABN AMRO Bank N.V. decreased its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 5.7% in the 1st quarter, HoldingsChannel reports. The firm owned 1,507,466 shares of the industrial products company’s stock after selling 90,740 shares during the quarter. Xylem makes up 2.0% of ABN AMRO Bank N.V.’s holdings, making the stock its 20th biggest holding. ABN AMRO Bank N.V.’s holdings in Xylem were worth $181,979,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Orion Porfolio Solutions LLC grew its stake in Xylem by 1.0% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock worth $1,151,000 after purchasing an additional 74 shares in the last quarter. Journey Strategic Wealth LLC raised its position in Xylem by 1.5% in the 3rd quarter. Journey Strategic Wealth LLC now owns 5,107 shares of the industrial products company’s stock valued at $753,000 after purchasing an additional 77 shares in the last quarter. Quest Investment Management LLC raised its position in Xylem by 1.0% in the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock valued at $1,119,000 after purchasing an additional 77 shares in the last quarter. Keel Point LLC boosted its stake in shares of Xylem by 4.6% in the 3rd quarter. Keel Point LLC now owns 1,784 shares of the industrial products company’s stock valued at $263,000 after buying an additional 79 shares during the period. Finally, SWS Partners boosted its stake in shares of Xylem by 1.1% in the 4th quarter. SWS Partners now owns 7,402 shares of the industrial products company’s stock valued at $1,008,000 after buying an additional 82 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Price Performance
Shares of XYL opened at $116.60 on Friday. The company has a market capitalization of $27.71 billion, a price-to-earnings ratio of 29.00, a price-to-earnings-growth ratio of 1.66 and a beta of 1.04. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The firm has a 50-day simple moving average of $113.05 and a 200-day simple moving average of $125.38. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.
Xylem Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.
Analysts Set New Price Targets
A number of research firms recently weighed in on XYL. JPMorgan Chase & Co. cut their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Stifel Nicolaus dropped their price objective on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Oppenheimer reduced their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Barclays decreased their price objective on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. Finally, CLSA upgraded shares of Xylem to a “hold” rating in a research note on Thursday. Eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average price target of $153.54.
View Our Latest Stock Analysis on XYL
Insider Transactions at Xylem
In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.32% of the stock is owned by company insiders.
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
